"Global Immuno-Oncology Assays Market Overview:
Global Immuno-Oncology Assays Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Immuno-Oncology Assays Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Immuno-Oncology Assays involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Immuno-Oncology Assays Market:
The Immuno-Oncology Assays Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Immuno-Oncology Assays Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Immuno-Oncology Assays Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Immuno-Oncology Assays market has been segmented into:
Consumables and Software
By Application, Immuno-Oncology Assays market has been segmented into:
Immunoassay
PCR
NGS
Fow Cytometry
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Immuno-Oncology Assays market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Immuno-Oncology Assays market.
Top Key Players Covered in Immuno-Oncology Assays market are:
Charles River Laboratories
F. Hoffmann-La Roche Ltd
lluminainc.
Agilent Technologiesinc.
Thermo Fisher Scientific Inc.
Merck KGaA
Invivoscribeinc.
QIAGEN
PerkinElmer Inc.
Sartorius AG
Bio-Rad Laboratoriesinc.
Bruker Spatial Biologyinc.
Nexelis
Reaction Biology
Crown Bioscience
HTG Molecular Diagnosticsinc.
Axion BioSystemsinc
BioTherapeutics LLC
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Immuno-Oncology Assays Market by Type
4.1 Immuno-Oncology Assays Market Snapshot and Growth Engine
4.2 Immuno-Oncology Assays Market Overview
4.3 Consumables and Software
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Consumables and Software: Geographic Segmentation Analysis
Chapter 5: Immuno-Oncology Assays Market by Application
5.1 Immuno-Oncology Assays Market Snapshot and Growth Engine
5.2 Immuno-Oncology Assays Market Overview
5.3 Immunoassay
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Immunoassay: Geographic Segmentation Analysis
5.4 PCR
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 PCR: Geographic Segmentation Analysis
5.5 NGS
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 NGS: Geographic Segmentation Analysis
5.6 Fow Cytometry
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Fow Cytometry: Geographic Segmentation Analysis
5.7 and Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Immuno-Oncology Assays Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CHARLES RIVER LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 F. HOFFMANN-LA ROCHE LTD
6.4 LLUMINAINC.
6.5 AGILENT TECHNOLOGIESINC.
6.6 THERMO FISHER SCIENTIFIC INC.
6.7 MERCK KGAA
6.8 INVIVOSCRIBEINC.
6.9 QIAGEN
6.10 PERKINELMER INC.
6.11 SARTORIUS AG
6.12 BIO-RAD LABORATORIESINC.
6.13 BRUKER SPATIAL BIOLOGYINC.
6.14 NEXELIS
6.15 REACTION BIOLOGY
6.16 CROWN BIOSCIENCE
6.17 HTG MOLECULAR DIAGNOSTICSINC.
6.18 AXION BIOSYSTEMSINC
6.19 AND BIOTHERAPEUTICS LLC
Chapter 7: Global Immuno-Oncology Assays Market By Region
7.1 Overview
7.2. North America Immuno-Oncology Assays Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Consumables and Software
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Immunoassay
7.2.5.2 PCR
7.2.5.3 NGS
7.2.5.4 Fow Cytometry
7.2.5.5 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Immuno-Oncology Assays Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Consumables and Software
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Immunoassay
7.3.5.2 PCR
7.3.5.3 NGS
7.3.5.4 Fow Cytometry
7.3.5.5 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Immuno-Oncology Assays Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Consumables and Software
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Immunoassay
7.4.5.2 PCR
7.4.5.3 NGS
7.4.5.4 Fow Cytometry
7.4.5.5 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Immuno-Oncology Assays Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Consumables and Software
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Immunoassay
7.5.5.2 PCR
7.5.5.3 NGS
7.5.5.4 Fow Cytometry
7.5.5.5 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Immuno-Oncology Assays Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Consumables and Software
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Immunoassay
7.6.5.2 PCR
7.6.5.3 NGS
7.6.5.4 Fow Cytometry
7.6.5.5 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Immuno-Oncology Assays Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Consumables and Software
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Immunoassay
7.7.5.2 PCR
7.7.5.3 NGS
7.7.5.4 Fow Cytometry
7.7.5.5 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Immuno-Oncology Assays Scope:
|
Report Data
|
Immuno-Oncology Assays Market
|
|
Immuno-Oncology Assays Market Size in 2025
|
USD XX million
|
|
Immuno-Oncology Assays CAGR 2025 - 2032
|
XX%
|
|
Immuno-Oncology Assays Base Year
|
2024
|
|
Immuno-Oncology Assays Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Charles River Laboratories, F. Hoffmann-La Roche Ltd, lluminainc., Agilent Technologiesinc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribeinc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratoriesinc., Bruker Spatial Biologyinc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnosticsinc., Axion BioSystemsinc, and BioTherapeutics LLC.
|
|
Key Segments
|
By Type
Consumables and Software
By Applications
Immunoassay
PCR
NGS
Fow Cytometry
and Others
|
